|
Name |
Exophillic acid
|
Molecular Formula | C38H56O12 | |
IUPAC Name* |
2-hydroxy-4-[4-hydroxy-2-nonyl-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybenzoyl]oxy-6-nonylbenzoic acid
|
|
SMILES |
CCCCCCCCCC1=C(C(=CC(=C1)O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)C(=O)OC3=CC(=C(C(=C3)O)C(=O)O)CCCCCCCCC
|
|
InChI |
InChI=1S/C38H56O12/c1-3-5-7-9-11-13-15-17-24-19-26(40)21-29(49-38-35(44)34(43)33(42)30(23-39)50-38)32(24)37(47)48-27-20-25(31(36(45)46)28(41)22-27)18-16-14-12-10-8-6-4-2/h19-22,30,33-35,38-44H,3-18,23H2,1-2H3,(H,45,46)/t30-,33-,34+,35-,38-/m1/s1
|
|
InChIKey |
GBXMNTLQBMLGFM-IHQQTPIISA-N
|
|
Synonyms |
Exophillic acid; 2-hydroxy-4-[4-hydroxy-2-nonyl-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybenzoyl]oxy-6-nonylbenzoic acid; 2-hydroxy-4-[4-hydroxy-2-nonyl-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-benzoyl]oxy-6-nonyl-benzoic acid; Benzoic acid, 2-(.beta.-D-glucopyranosyloxy)-4-hydroxy-6-nonyl-, 4-carboxy-3-hydroxy-5-nonylphenyl ester
|
|
CAS | NA | |
PubChem CID | 3008194 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 704.8 | ALogp: | 9.7 |
HBD: | 7 | HBA: | 12 |
Rotatable Bonds: | 23 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 203.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 50 | QED Weighted: | 0.044 |
Caco-2 Permeability: | -5.863 | MDCK Permeability: | 0.00001290 |
Pgp-inhibitor: | 0.896 | Pgp-substrate: | 0.941 |
Human Intestinal Absorption (HIA): | 0.922 | 20% Bioavailability (F20%): | 0.999 |
30% Bioavailability (F30%): | 0.998 |
Blood-Brain-Barrier Penetration (BBB): | 0.022 | Plasma Protein Binding (PPB): | 99.99% |
Volume Distribution (VD): | 0.364 | Fu: | 0.67% |
CYP1A2-inhibitor: | 0.247 | CYP1A2-substrate: | 0.083 |
CYP2C19-inhibitor: | 0.073 | CYP2C19-substrate: | 0.055 |
CYP2C9-inhibitor: | 0.191 | CYP2C9-substrate: | 0.332 |
CYP2D6-inhibitor: | 0.873 | CYP2D6-substrate: | 0.11 |
CYP3A4-inhibitor: | 0.084 | CYP3A4-substrate: | 0.002 |
Clearance (CL): | 1.826 | Half-life (T1/2): | 0.593 |
hERG Blockers: | 0.49 | Human Hepatotoxicity (H-HT): | 0.193 |
Drug-inuced Liver Injury (DILI): | 0.966 | AMES Toxicity: | 0.092 |
Rat Oral Acute Toxicity: | 0.01 | Maximum Recommended Daily Dose: | 0.035 |
Skin Sensitization: | 0.899 | Carcinogencity: | 0.023 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.054 |
Respiratory Toxicity: | 0.086 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003312 | 0.722 | D00STJ | 0.375 | ||||
ENC003334 | 0.448 | D0T9TJ | 0.302 | ||||
ENC002894 | 0.444 | D07ILQ | 0.301 | ||||
ENC004641 | 0.436 | D06BQU | 0.276 | ||||
ENC005852 | 0.429 | D00FGR | 0.274 | ||||
ENC004642 | 0.407 | D0O1PH | 0.273 | ||||
ENC002672 | 0.401 | D0P1RL | 0.273 | ||||
ENC002909 | 0.391 | D0TC7C | 0.273 | ||||
ENC002194 | 0.391 | D0I9HF | 0.272 | ||||
ENC005817 | 0.391 | D00AOJ | 0.272 |